Children's Hospitals and Clinics of Minnesota
Trial Pipeline
Fetoscopic Endoluminal Tracheal Occlusion
NCT05771688
International PPB/DICER1 Registry
NCT03382158
International Ovarian & Testicular Stromal Tumor Registry
NCT01970696
International Pleuropulmonary Blastoma (PPB) Treatment and Biology Registry
NCT01464606
Firearm Screening in the Pediatric Emergency Department
NCT07482982
Pro-calcitonin for Early Detection of Septic Arthritis
NCT02085733
Diagnosis of Mucopolysaccharidosis Disorders in Patients Presenting With Bilateral Hip Disease
NCT01707433
Probiotics in the Treatment of Iron Deficiency in Children With Restless Leg Syndrome
NCT01617044
Animated Picture to Improve Provider Adherence to CT Scan for Head Injury Rule
NCT01514071
Effects of Exenatide on Hypothalamic Obesity
NCT01061775
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
What the Pipeline for Children's Hospitals and Clinics of Minnesota Shows
According to the ClinicalTrials.gov registry, Children's Hospitals and Clinics of Minnesota is linked to 41 US clinical trials across every stage of research activity. Of those, 34 studies are currently recruiting — about 83% of the sponsor's indexed portfolio — and 6 are already marked complete, representing roughly 15% of the total. Recruiting share is one of the more practical signals here: it reflects how much of a sponsor's research is presently open to new participants, while the completed share indicates the depth of finished work that has already contributed registry results. Both counts come directly from the public ClinicalTrials.gov dataset and are refreshed on the registry side; this page mirrors the latest data pull without altering it.
The phase mix for Children's Hospitals and Clinics of Minnesota reports 0 late-stage studies (Phase 3 and Phase 4 combined) and 2 earlier-phase studies (Phase 1 and Phase 2). A portfolio weighted toward Phase 3 usually reflects an organization advancing candidates toward regulatory review, where the research centers on comparative efficacy and broader safety across larger populations. A heavier Phase 1 and Phase 2 tilt generally indicates exploratory work — safety, dosing, and early signal detection — and is common among research-forward sponsors that seed many early programs. Phase 4 entries, when present, track interventions already in real-world use and typically focus on long-term safety, effectiveness across subgroups, or formulation comparisons.
The top therapeutic focus area indexed for Children's Hospitals and Clinics of Minnesota is Pleuropulmonary Blastoma with 2 linked trials, and 9 other condition areas appear in the top list above. That distribution is a quick read of where the organization concentrates its research attention; it does not imply product availability, market share, or any clinical endorsement. All numbers on this page come from ClinicalTrials.gov maintained by the National Library of Medicine, and counts can shift as new studies are registered or existing ones update their status. This information is provided for reference and educational purposes only, not as medical, investment, or regulatory advice — verify current details directly with ClinicalTrials.gov before relying on any figure here.
Read our methodology — how this data is sourced, computed, and verified.